Novan to Present at Piper Jaffray 29th Annual Healthcare Conference
November 22 2017 - 8:25AM
Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today
announced that Nathan Stasko, PhD, President and Chief Scientific
Officer of Novan, is scheduled to participate in a fireside chat at
the Piper Jaffray 29th Annual Healthcare Conference, Wednesday,
Nov. 29, 2017, 12:00 p.m. EST, in New York.
The presentation will be webcast live and can be
accessed through the Investor Relations section of the Company's
website at www.Novan.com. An archived version of the webcast will
be available approximately two hours following the live
presentation for 30 days.
About Novan
Novan, Inc. is a clinical-stage biotechnology
company focused on leveraging nitric oxide’s natural antiviral and
immunomodulatory mechanisms of action to treat dermatological and
oncovirus-mediated diseases. We believe that our ability to
conveniently deploy nitric oxide in a solid form, on demand and in
localized formulations allows us the potential to significantly
improve patient outcomes in a variety of diseases.
CONTACT:
(Investors)Novan, Inc.investors@novan.com
(Media)Cari GreenDirector, Corporate Communications and
Administrationcgreen@novan.com
Novan (NASDAQ:NOVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novan (NASDAQ:NOVN)
Historical Stock Chart
From Apr 2023 to Apr 2024